» Articles » PMID: 28302118

YBX1 Gene Silencing Inhibits Migratory and Invasive Potential Via CORO1C in Breast Cancer in Vitro

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2017 Mar 18
PMID 28302118
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Y-box binding protein-1 is an evolutionary conserved transcription and translation regulating protein that is overexpressed in various human malignancies, including breast cancer. Despite reports of YB-1 and its association with distant spread of breast cancer, the intrinsic mechanism underlying this observation remains elusive. This study investigates the role of YB-1 in mediating metastasis in highly invasive breast cancer cell lines.

Methods: Silencing the YBX1 gene (which encodes the YB-1 protein) by small interfering RNA (siRNA) was performed in MDA-MB-231 and Hs578T breast cancer cell lines, followed by phenotypic assays including cell migration and invasion assays. Gene expression profiling using Affymetrix GeneChip® Human Transcriptome 2.0 array was subsequently carried out in YB-1 silenced MDA-MB-231 cells. Overexpression and silencing of YBX1 were performed to assess the expression of CORO1C, one of the differentially regulated genes from the transcriptomic analysis. A Gaussia luciferase reporter assay was used to determine if CORO1C is a putative YB-1 downstream target. siRNA-mediated silencing of CORO1C and down-regulation of YBX1 in CORO1C overexpressing MDA-MB-231 cells were performed to evaluate cell migration and invasion.

Results: Downregulation of the YB-1 protein inhibited cell migration and invasion in MDA-MB-231 breast cancer cells. Global gene expression profiling in the YBX1 silenced MDA-MB-231 cells identified differential expression of several genes, including CORO1C (which encodes for an actin binding protein, coronin-1C) as a potential downstream target of YB-1. While knockdown of YBX1 gene decreased CORO1C gene expression, the opposite effects were seen in YB-1 overexpressing cells. Subsequent verification using the reporter assay revealed that CORO1C is an indirect downstream target of YB-1. Silencing of CORO1C by siRNA in MDA-MB-231 cells was also observed to reduce cell migration and invasion. Silencing of YBX1 caused a similar reduction in CORO1C expression, concomitant with a significant decrease in migration in Hs578T cells. In coronin-1C overexpressing MDA-MB-231 cells, increased migration and invasion were abrogated by YB-1 knockdown.

Conclusion: It would appear that YB-1 could regulate cell invasion and migration via downregulation of its indirect target coronin-1C. The association between YB-1 and coronin-1C offers a novel approach by which metastasis of breast cancer cells could be targeted and abrogated.

Citing Articles

Biological functions of 5-methylcytosine RNA-binding proteins and their potential mechanisms in human cancers.

Zhao T, Zhang Z, Chen Z, Xu G, Wang Y, Wang F Front Oncol. 2025; 15:1534948.

PMID: 39990690 PMC: 11842269. DOI: 10.3389/fonc.2025.1534948.


CORO1C Regulates the Malignant Biological Behavior of Ovarian Cancer Cells and Modulates the mRNA Expression Profile through the PI3K/AKT Signaling Pathway.

Lu N, Guo Y, Ren L, Zhao H, Yan L, Han H Cell Biochem Biophys. 2024; .

PMID: 39433598 DOI: 10.1007/s12013-024-01591-4.


Proteomic insights into breast cancer response to brain cell-secreted factors.

Ahuja S, Lazar I Sci Rep. 2024; 14(1):19351.

PMID: 39169222 PMC: 11339284. DOI: 10.1038/s41598-024-70386-7.


Stress granules in cancer: Adaptive dynamics and therapeutic implications.

Jia Y, Jia R, Dai Z, Zhou J, Ruan J, Chng W iScience. 2024; 27(8):110359.

PMID: 39100690 PMC: 11295550. DOI: 10.1016/j.isci.2024.110359.


Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple-Negative Breast Cancer.

Tian W, Zhu L, Luo Y, Tang Y, Tan Q, Zou Y Adv Sci (Weinh). 2024; 11(36):e2309903.

PMID: 39073262 PMC: 11423137. DOI: 10.1002/advs.202309903.


References
1.
Bergmann S, Royer-Pokora B, Fietze E, Jurchott K, Hildebrandt B, Trost D . YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification. Cancer Res. 2005; 65(10):4078-87. DOI: 10.1158/0008-5472.CAN-04-4056. View

2.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

3.
Chernov K, Curmi P, Hamon L, Mechulam A, Ovchinnikov L, Pastre D . Atomic force microscopy reveals binding of mRNA to microtubules mediated by two major mRNP proteins YB-1 and PABP. FEBS Lett. 2008; 582(19):2875-81. DOI: 10.1016/j.febslet.2008.07.019. View

4.
Janz M, Harbeck N, Dettmar P, Berger U, Schmidt A, Jurchott K . Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1. Int J Cancer. 2002; 97(3):278-82. DOI: 10.1002/ijc.1610. View

5.
Chan K, Creed S, Bear J . Unraveling the enigma: progress towards understanding the coronin family of actin regulators. Trends Cell Biol. 2011; 21(8):481-8. PMC: 3163407. DOI: 10.1016/j.tcb.2011.04.004. View